Zepbound® (Tirzepatide) Injection 12.5 mg/0.5 mL

Description

Zepbound® (Tirzepatide) Injection 12.5 mg/0.5 mL. Zepbound contains tirzepatide, a dual-action medication that activates both GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors. These two hormones work together to regulate appetite, slow digestion, improve metabolic signaling, and reduce caloric intake. By targeting both pathways, Zepbound helps patients feel fuller sooner, stay full longer, and experience reduced hunger between meals.

The 12.5 mg dose is typically prescribed after patients have successfully titrated through lower doses and require additional appetite suppression and weight-loss support. Each carton includes four single-use, pen-style prefilled syringes, with one injection administered per week. Zepbound is designed for convenient at-home use under the guidance of a licensed healthcare provider.

Zepbound is not insulin and is not approved to treat type 1 or type 2 diabetes, though it may improve metabolic markers in patients with insulin resistance.

---

How Zepbound Is Used

Zepbound is injected once weekly, on the same day each week, just under the skin of the abdomen, thigh, or upper arm. Injection sites should be rotated weekly to minimize skin irritation.

Before injecting, the pen should be inspected to ensure the solution is clear and the medication has not expired. After cleaning the injection site with an alcohol swab, the pen is activated according to the manufacturer’s instructions. Once the dose is delivered, the needle is safely shielded.

Each pen is intended for single use only and must be disposed of in an approved sharps container. Patients should never share injection pens.

If a dose is missed, it may be taken as soon as remembered, as long as the next scheduled dose is at least three days away. Patients should not take two doses within the same week unless directed by their healthcare provider.

---

Storage Information

Zepbound pens must be stored in the refrigerator and should never be frozen. Because this medication requires refrigeration, an adult recipient must be available at delivery to ensure proper handling.

---

Important Medical Information

Zepbound is available by prescription only and should be used exactly as directed by a licensed healthcare provider. Weight loss results vary, and it may take several weeks to see noticeable changes. Patients should continue following a reduced-calorie diet and increased physical activity plan while using Zepbound.

Your healthcare provider will determine whether Zepbound is appropriate based on your medical history, BMI, and weight-loss goals.

---

What Makes Zepbound Different?

Zepbound uses the same active ingredient as Mounjaro® (tirzepatide) but is specifically FDA-approved for weight management. By targeting both GLP-1 and GIP receptors, Zepbound offers stronger appetite control and metabolic support than GLP-1–only medications, making it one of the most advanced prescription weight-loss injections available in the U.S.